Depression Clinical Trial
Official title:
Affective Modulation of Positivity for Alcohol Use Disorder (AMP-A): Feasibility and Pilot Study
The proposed study is a pilot study examining the feasibility and potential utility of administering a psychosocial intervention termed Affective Modulation of Positivity (AMP) for individuals suffering from co-morbid depression or anxiety disorders and alcohol use disorder (AMP-A). The aims of this study are to (1) determine the feasibility and potential utility of administering AMP-A with individuals suffering from alcohol use disorders, (2) explore the potential impact of training on positive and negative affect, symptom severity, and functional disability, and (3) explore the potential impact of training on neural reactivity to reward and alcohol cues during functional magnetic resonance imaging (fMRI).
This study is a non-randomized, single-arm, single-site clinical trial conducted at Laureate
Institute for Brain Research (LIBR) in Tulsa, OK. The primary objective for this study is to
examine the feasibility and acceptability of conducting positive affect training with
individuals suffering from substance use disorder. Primary outcome will include treatment
completion rate; secondary outcome will include the score on a participant feedback
questionnaire. The investigators hypothesize that the majority of participants (>60%) will
complete all 11 sessions of the intervention and that participant feedback concerning the
intervention will be at least moderately favorable on average.The secondary objective(s) is
to explore the potential impact of training on positive and negative affect, symptom
severity, and functional disability. The investigators hypothesize that positive affect will
significantly increase from baseline to post-intervention, while negative affect,
alcohol-related craving, and functional disability will significantly decrease. A tertiary
objective is to explore the potential impact of training on behavioral and neural responses
involving the processing of positively valenced or alcohol-related cues. The investigators
hypothesize that activation with striatal and orbitofrontal cortex (OFC) regions to
alcohol-UNrelated reward cues will increase from baseline to post-intervention, while
striatal and OFC response to alcohol-related cues will decrease from baseline to
post-intervention.
Participants will be asked to complete interview and pencil-and-paper questionnaires related
to clinical symptoms, traits and personality characteristics, daily life function, and
medical and mental health history at both pre- and post-intervention. Participants will also
be asked to complete brief follow-up survey sessions 3 months after completing treatment. If
there are participants who are only able to complete part of the intervention (i.e., only
able to attend a few of the sessions) either due to their own wish to terminate or due to
exclusion criteria or clinical concerns, they will only be asked to complete survey sessions
for weeks that they attend. Neuroimaging procedures will be conducted at both pre- and
post-intervention. Each neuroimaging session will last approximately 1.5-2.5 hours and will
involve completion of self-report measures regarding current affective state and sleepiness
and a functional MRI session during which participants will complete tasks related to reward
processing and alcohol cue reactivity.
Following completion of baseline assessments, participants will be asked to complete 11
sessions of the positive affect intervention, conducted once or twice weekly and with each
session lasting 1 - 1.5 hours. If the content of sessions is too much to cover for any one
client, the intervention may be extended to 13 sessions as needed. Participants will be
expected to complete all intervention sessions within 16 weeks of starting the first session.
Each session will be completed as individual therapy sessions (i.e., one-on-one with a
therapist). The positive affect intervention will involving positive emotion enhancement
exercises established in prior studies, including noticing and amplifying positive emotions,
practicing gratitude, engaging in acts of kindness, and pleasurable or meaningful activities,
identifying strengths and values, being optimistic, engaging in activities meant to make
others happy, and living life to its fullest. The investigators will use the protocol
developed by Taylor et al. with modifications to specifically address alcohol use, based on
previous work. The general structure of each session will follow standard cognitive
behavioral treatment regimens as follows: (1) meet with clinician to review completion of the
prior week's exercises, including self-monitoring forms of emotions and exercise completion;
(2) identify and troubleshoot any issues that arose during exercise completion; (3) introduce
material about a new positive emotion enhancement activity; (4) identify concrete exercises
to implement for the upcoming week.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |